SPOTLIGHT: GAO asked to probe FDA on discipline


Not to be outdone by Democrats calling for pharma-related investigations by the Government Accountability Office, two Republican Congressmen are asking the GAO to probe the FDA's methods for disciplining researchers who break drug-trial rules. Rep. Joe Barton and John Shimkus wrote a letter to the government auditor, saying that FDA oversight of trials needs to be reviewed. Report

Suggested Articles

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.

More than half of the participants met the primary endpoint, teeing Sanofi up to file for FDA approval of the complement C1s inhibitor.

Cellarity is combining artificial intelligence, a protein discovery platform and what it calls “network biology” in a new drug discovery approach.